Special Correspondent

Complaint lodged by a patient that the drugs were ineffective.

VISAKHAPATNAM: Aurangabad-based Wokhardt Limited has recalled from the market throughout India one lakh vials of Wosulin 50/50 and 30/70 of four batch numbers, an insulin produced by it, at the direction of the DCA of Andhra Pradesh. The market value was approximately Rs.1.3 crores. This was for the first time in the history of DCA that drugs worth such an amount had been recalled, said drugs inspector Ravi Udaya Bhaskar here on Saturday.

Vice-president of Wokhardt Limited met the drugs inspector here and briefed him about the steps being taken for completely recalling the drug from the market.